Modulation of EGFR expression by gain-of-function and loss-of-function strategies in glioblastoma cancer stem cell lines enhances and reduces their tumorigenic ability, respectively, suggesting a key role of EGFR in gliomagenesis [293]. The gene discussed is EGFR; the disease is glioblastoma.